Reporting Owner Activity for Louis W. Sullivan

Form 3/4/5 issuer positions and transaction evidence for this reporting owner.

Issuer positions

2

Largest position

UNITED THERAPEUTICS Corp

Disclosed value

$2.35M

Recent activity

Available

SEC ownership signals
Ownership summary

Disclosed holdings value

$2,349,634

Estimated from parsed Forms 3/4/5 holdings when values are available.

Issuer positions

2

Distinct issuers linked to this reporting owner in parsed SEC filings.

Largest parsed position

UNITED THERAPEUTICS Corp (UTHR)

About $1.74M reported in parsed filings.

Latest ownership filing

23 Dec 2025

Most recent owner-level filing date in the parsed SEC record.

Values come from parsed SEC Forms 3/4/5 and should be verified against the source filing.

SEC record
Reporting signature
/s/ John S. Hess, Jr. under Power of Attorney
SEC evidence

Follow Filing Activity

Follow Louis W. Sullivan and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Reported issuer positions for Louis W. Sullivan

UTHR Forms 3/4/5

UNITED THERAPEUTICS Corp

Relationship
Director
Holdings value
$1,738,994
Past year net change
-$3,047,201
Change %
-64%
Report period
22 Dec 2025

Insider Transactions Reported by Louis W. Sullivan:

Sym Company Class Transaction % Reported value Reported price Shares Shares after Date Ownership
* indicates a reported price that failed the local validity check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .